Newspaper Advertisement Regarding Notice Of The 26Th Annual General Meeting
The company has published the AGM Notice''s advertisement in the following newspapers on 4th September, 2018: 1. Free Press Journal- English Daily- (Mumbai Edition) 2. Navshakti- Marathi Daily- (Mumbai Edition) Notice Of 26Th Annual General Meeting
Notice of 26th Annual General Meeting of the Company to be held on Thursday, 27th September, 2018. Outcome of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the company, at its meeting held today, i.e. August 31, 2018 have considered and approved the allotment of 16,00,000 Equity shares of the company of face value of Rs. 10/- each at a price of Rs. 59/- per share (including a premium of Rs. 49/- per share) upon conversion of 16,00,000 Warrants issued... Board Meeting Intimation for Consideration Of The Conversion Of 16,00,000 Warrants Issued At A Price Of Rs. 59/- Per Warrant And Allotment Of 16,00,000 Equity Shares Of Face Value Of Rs. 10/- Each Pursuant To Such Conversion Of Warrants
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2018 ,inter alia, to consider and approve the conversion of 16,00,000 Warrants issued at a price of Rs. 59/- per warrant and allotment of 16,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants.... Announcement under Regulation 30 (LODR)-Demise
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 we here informing about the sad demise of Mr. Ramesh Modi, Independent Director of the Company as on 22nd August, 2018. Disclosure Of Information Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 we be and hereby inform you that our Director, Mr. Bhavin Mehta has received the appreciation letter from Consulate General of the Federal Democratic Republic of Ethiopia, Mumbai for the Presentation made at Seminar entitled 'Interactive Seminar on opportunities in Ethiopia, Avenues and Incentives' organised by Hindu Economic Forum on August 17, 2018. Fixes Book Closure for Dividend & AGM
Kilitch Drugs India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2018 to September 27, 2018 (both days inclusive) for the purpose of Payment of Dividend & 26th Annual General Meeting (AGM) of the Company to be held on September 27, 2018. Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclosed herewith our Press Release relating to Financial Results of Quarter-1 of Financial Year 2018-19. Kilitch Drugs Eyes African Markets To Fuel Growth (Setup Of Manufacturing Unit On 12400 Sqm Of Land In Ethiopia)
Kilitch Drugs (India) Ltd. (KDIL), has informed that, it has planned to focus on African markets with a state-of-the-art Cephalosporin injectable plant near Adis Ababa - capital city of Ethiopia.The unit will have a capacity of 20 million vials and commence operations in FY 2019 - 2020. Besides vials, the plant will also produce tablets, capsules, dry syrup, etc....